Molecular Templates, Inc.: restructuring charge — Molecular Templates cuts 60% of workforce (19 employees) to extend cash runway

Molecular Templates, Inc.

Board approved reduction in force of 19 employees, approximately 60% of total workforce, on Oct 3, 2024.
Company expects negligible costs from the layoffs, primarily legal and termination fees.
Implementation expected to be substantially complete in October 2024.
Company continues to evaluate strategic alternatives, including potential sale or merger.

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

Molecular Templates, Inc. announced a restructuring with charges of a negligible amount (19 employees (approximately 60% of the Company’s employees)).

Type: restructuring
Charge: a negligible amount
Headcount: 19 employees (approximately 60% of the Company’s employees)

Exact text from the filing

On October 3, 2024, the Board approved a reduction in force of 19 employees (approximately 60% of the Company’s employees), in order to extend its resources and allow the Company to continue to support its clinical studies and its efforts to maximize the value of the business and its assets. The Company estimates that it will incur a negligible amount of costs in connection with the reduction in force, primarily consisting of legal fees and other related termination costs.

View on SEC.gov

Browse all restructurings & charges →

Source: SEC EDGAR

accession 0001193125-24-233039

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.